FDA Oncology Announcements

EZH inhibitor × Sarcoma × Clear all

2 Announcements

FDA approves tazemetostat for advanced epithelioid sarcoma

Drug: TAZVERIK (tazemetostat) · EZH inhibitor
Condition: Sarcoma

FDA approves tazemetostat for advanced epithelioid sarcoma

Drug: TAZVERIK (tazemetostat) · EZH inhibitor
Condition: Sarcoma